Molecular and Pharmacological Characterization of GABAAReceptor α1 Subunit Knockout Mice
- 1 September 2002
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 302 (3), 1037-1045
- https://doi.org/10.1124/jpet.102.036665
Abstract
GABAA receptors mediate fast inhibitory neurotransmission in the central nervous system (CNS), and approximately half of these receptors contain α1 subunits. GABAA receptor α1 subunits are important for receptor assembly and specific pharmacological responses to benzodiazepines. Plasticity in GABAA receptor α1 subunit expression is associated with changes in CNS excitability observed during normal brain development, in animal models of epilepsy, and upon withdrawal from alcohol and benzodiazepines. To examine the role of α1 subunit-containing GABAA receptors in vivo, we characterized receptor subunit expression and pharmacological properties in cerebral cortex of knockout mice with a targeted deletion of the α1 subunit. The mice are viable but exhibit an intention tremor. Western blot analysis confirms the complete loss of α1 subunit peptide expression. Stable adaptations in the expression of several GABAA receptor subunits are observed in the fifth to seventh generations, including decreased expression of β2/3 and γ2 subunits and increased expression of α2 and α3 subunits. There was no change in α4, α5, or δ subunit peptide levels in cerebral cortex. Knockout mice exhibit loss of over half of GABAA receptors measured by [3H]muscimol, [3H]2-(3-carboxyl)-3-amino-6-(4-methoxyphenyl)-pyridazinium bromide ([3H]SR-95531), andt-butylbicyclophosphoro[35S]thionate ([35S]TBPS) binding. [3H]Ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate ([3H]Ro15-4513) binding is reduced by variable amounts in different regions across brain. GABAA receptor α1−/− mice lose all high-affinity [3H]zolpidem binding and about half of [3H]flunitrazepam binding in the cerebral cortex. The potency and maximal efficacy of muscimol-stimulated36Cl− uptake in cerebral cortical synaptoneurosomes are reduced in α1−/− mice. Furthermore, knockout mice exhibit increased bicuculline-induced seizure susceptibility compared with wild-type mice. These data emphasize the significance of α1 subunit expression and its involvement in the regulation of CNS excitability.Keywords
This publication has 45 references indexed in Scilit:
- Effects of treatment with GABAA receptor subunit antisense oligodeoxynucleotides on GABA-stimulated 36Cl− influx in the rat cerebral cortexNeurochemistry International, 2000
- Structure and subunit composition of GABAA receptorsNeurochemistry International, 1999
- Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptorsBritish Journal of Pharmacology, 1998
- Pharmacology of recombinant γ‐aminobutyric acidA receptors rendered diazepam‐insensitive by point‐mutated α‐subunitsFEBS Letters, 1998
- The benzodiazepine binding site of GABAA receptorsTrends in Pharmacological Sciences, 1997
- Characterisation of δ-subunit containing GABAA receptors from rat brainEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Polyclonal Antibodies Directed Against an Epitope Specific for the α4‐Subunit of GABAA Receptors Identify a 67‐kDa Protein in Rat Brain MembranesJournal of Neurochemistry, 1994
- Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunitFEBS Letters, 1991
- Effects of Progabide on Bicuculline-Induced Epileptic Seizures in Developing RatsClinical Neuropharmacology, 1988
- A novel GABAA antagonist [3H]SR 95531: Microscopic analysis of binding in the rat brain and allosteric modulation by several benzodiazepine and barbiturate receptor ligandsSynapse, 1987